Solid Biosciences Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alexander G. Cumbo, with a market cap of $699.6M.
Common questions about Solid Biosciences Inc.
Solid Biosciences Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026.
Solid Biosciences Inc. has approximately 88 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.